PAX translocations remodel mitochondrial metabolism through altered leucine usage in rhabdomyosarcoma


Por: Kalita, B, Martinez-Cebrian, G, McEvoy, J, Allensworth, M, Knight, M, Magli, A, Perlingeiro, RCR, Dyer, MA, Stewart, E and Dynlacht, BD

Publicada: 15 may 2025 Ahead of Print: 1 may 2025
Resumen:
Alveolar rhabdomyosarcoma (ARMS) patients harboring paired-box fusion proteins (PAX3/7-FOXO1) exhibit a greater incidence of tumor relapse, metastasis, and poor survival outcome, thereby underscoring the urgent need to develop effective therapies to treat this subtype of childhood cancer. To uncover mechanisms that contribute to tumor initiation, we develop a muscle progenitor model and use epigenomic approaches to unravel genome rewiring events mediated by PAX3/7 fusion proteins. Among the key targets of PAX3/7 fusion proteins, we identify a cohort of oncogenes, fibroblast growth factor (FGF) receptors, tRNA-modifying enzymes, and genes essential for mitochondrial metabolism and protein translation, which we successfully targeted in preclinical trials. We identify leucine usage as a key factor driving the growth of aggressive PAX-fusion tumors, as limiting its bioavailability impaired oxidative phosphorylation and mitochondrial metabolism, delaying tumor progression and improving survival in vivo. Our data provide a compelling list of actionable targets and suggest promising new strategies to treat this tumor.

Filiaciones:
Kalita, B:
 NYU, Sch Med, Dept Pathol, New York, NY 10016 USA

 NYU, Perlmutter Canc Inst, Sch Med, New York, NY 10016 USA

:
 NYU, Sch Med, Dept Pathol, New York, NY 10016 USA

 NYU, Perlmutter Canc Inst, Sch Med, New York, NY 10016 USA

 Josep Carreras Leukaemia Res Inst, Badalona 08916, Spain

McEvoy, J:
 St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl,MS 323, Memphis, TN 38105 USA

Allensworth, M:
 St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl,MS 323, Memphis, TN 38105 USA

Knight, M:
 St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl,MS 323, Memphis, TN 38105 USA

 St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA

Magli, A:
 Univ Minnesota, Lillehei Heart Inst, Dept Med, Minneapolis, MN 55455 USA

 Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA

 Sanofi, Genom Med Unit, 225nd Ave, Waltham, MA 02451 USA

Perlingeiro, RCR:
 Univ Minnesota, Lillehei Heart Inst, Dept Med, Minneapolis, MN 55455 USA

Dyer, MA:
 St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl,MS 323, Memphis, TN 38105 USA

Stewart, E:
 St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl,MS 323, Memphis, TN 38105 USA

 St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA

Dynlacht, BD:
 NYU, Sch Med, Dept Pathol, New York, NY 10016 USA

 NYU, Perlmutter Canc Inst, Sch Med, New York, NY 10016 USA
ISSN: 00928674





Cell
Editorial
Cell Press, 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 188 Número: 10
Páginas: 2757-2777
WOS Id: 001494695200011
ID de PubMed: 40185100
imagen Green Submitted

MÉTRICAS